N-Des-(2-(3,4-Difluorophenyl)cyclopropyl)-O-(2-(3,4-Difluorophenyl)cyclopropyl) Ticagrelor-d7 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

N-Des-(2-(3,4-Difluorophenyl)cyclopropyl)-O-(2-(3,4-Difluorophenyl)cyclopropyl) Ticagrelor-d7 is the isotope labelled analog of N-Des-(2-(3,4-Difluorophenyl)cyclopropyl)-O-(2-(3,4-Difluorophenyl)cyclopropyl) Ticagrelor (D289715); an impurity of Ticagrelor (T437700) which is the first reversible oral P2Y12 receptor antagonist that provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Used in the treatment of acute coronary syndromes (ACS).

N-Des-(2-(3,4-Difluorophenyl)cyclopropyl)-O-(2-(3,4-Difluorophenyl)cyclopropyl) Ticagrelor-d7 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

N-Des-(2-(3,4-Difluorophenyl)cyclopropyl)-O-(2-(3,4-Difluorophenyl)cyclopropyl) Ticagrelor-d7 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
	4008-099-669	23419001name@qq.com	CHINA	73043	58
United States Biological	--	sales@advtechind.com	United States	6075	58

---

• N-Des-(2-(3,4-Difluorophenyl)cyclopropyl)-O-(2-(3,4-Difluorophenyl)cyclopropyl) Ticagrelor-d7